Diagnosis and implications of human cytomegalovirus infection in pregnancy

Fetal and Maternal Medicine Review

Volumn 11, Issue 3-4, 1999, Pages 117-134

  Revello, Maria Grazia ^a   Gerna, Giuseppe ^a  

^a FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

GANCICLOVIR; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; IMMUNOGLOBULIN M ANTIBODY;

AMNION FLUID ANALYSIS; ANTIBODY TITER; BETAHERPESVIRINAE; CLINICAL FEATURE; CLINICAL TRIAL; CYTOMEGALOVIRUS INFECTION; FETUS BLOOD SAMPLING; FETUS WASTAGE; HUMAN; IMMUNE RESPONSE; MOLECULAR DYNAMICS; PATHOGENESIS; PREGNANCY COMPLICATION; REVIEW; SEROCONVERSION; STILLBIRTH; VIRUS REPLICATION;

EID: 0033306094     PISSN: 09655395     EISSN: None     Source Type: Journal    
DOI: 10.1017/S0965539599000327     Document Type: Review

References (104)

1. Uber einen Befund von protozoenartigen Gebilden in den Organen eines hereditar-luetischen Fotus
2. Uber protozoenartige Zellen in der Niere eines syphilitischen Neugeborenen und in der Parotis von Kindern
3. Uber protozoenartige Gebilde in den Organen von Kindern
4. Propagation in tissue cultures of a cytopathogenic virus from salivary gland virus (SGV) disease
5. Isolation of intranuclear inclusion-producing agents from infants with illnesses resembling cytomegalic inclusion disease
6. The cytomegaloviruses: Ubiquitous agents with protean clinical manifestations
7. Congenital cytomegalovirus disease: A NOW problem
8. Congenital cytomegalovirus disease - 20 years is long enough
9. Fibroblasts, epithelial cells, endothelial cells and smooth muscle cells are major targets of human cytomegaloviurs infection in lung and gastrointestinal tissues
10. Widespread presence of histologically occult cytomegalovirus
11. Circulating cytomegalovirus (CMV)-infected endothelial cells in patients with active CMV infection
12. Circulating endothelial giant cells permissive for human cytomegalovirus (HCMV) are detected in disseminated HCMV infection with organ involvement
13. Interaction of cytomegalovirus with leukocytes from patients with mononucleosis due to cytomegalovirus
14. Rapid detection of human cytomegalovirus DNA in the peripheral blood leukocytes of viremic transplant recipients by the polymerase chain reaction
15. Localization of human cytomegalovirus in peripheral blood
16. Nuclear expression of the lower matrix phosphoprotein of human cytomegalovirus in peripheral blood leukocytes of immunocompromised viraemic patients
17. Cytomegalovirus transcripts in peripheral blood leukocytes of actively infected transplant patients detected by reverse transcription-polymerase chain reaction
18. Human cytomegalovirus infection of the major leukocyte subpopulations and evidence for initial viral replication in polymorphonuclear leukocytes from viremic patients
19. Immunohistochemical detection of an immediate-early antigen of human cytomegalovirus in normal tissues
20. Cytomegalovirus nucleic acid distribution within the human vascular tree
21. Latent and persistent infections of monocytes and macrophages
22. Molecular epidemiology of cytomegalovirus infections in women and their infants
23. Comparative virulence and immunogenicity of the Towne strain and a non attenuated strain of cytomegalovirus
24. Human cytomegalovirus clinical isolates carry at least 19 genes not found in laboratory strains
25. Dramatic interstrain differences in the replication of human cytomegalovirus in SCID-hu mice
26. In vitro generation of human cytomegalovirus pp65 antigenemia, viremia and leukoDNAemia
27. Prospective study of cytomegalovirus infection in pregnancy
28. Primary infection with cytomegalovirus during pregnancy
29. Congenital cytomegalovirus infection: The relative importance of primary and recurrent maternal infection
30. Congenital cytomegalovirus infection: Occurrence in an immune population
31. Primary cytomegalovirus infection in pregnancy. Incidence, transmission to fetus, and clinical outcome
32. Congenital cytomegalovirus infection in newborn infants of mothers infected before pregnancy
33. Intra-uterine transmission of cytomegalovirus in women known to be immune before conception
34. Cytomegalovirus
35. The outcome of congenital cytomegalovirus infection in relation to maternal antibody status
36. Secondary maternal cytomegalovirus infection causing symptomatic congenital infection
37. Cytomegalic inclusion disease after recurrent maternal infection
38. Symptomatic congenital cytomegalovirus infection after maternal recurrent infection
39. Symptomatic congenital cytomegalovirus infection in infants born to mothers with preexisting immunity to cytomegalovirus
40. Neonatal screening for congenital cytomegalovirus infections
41. Prevention of congenital cytomegalovirus disease
42. Antibody response to synthetic peptides from cytomegalovirus phosphoprotein 150
43. Early serodiagnosis of acute human cytomegalovirus infection by enzyme-linked immunosorbent assay using recombinant antigens
44. Recombinant mono- and polyantigens to detect cytomegalovirus-specific immunoglobulin M in human sera by enzyme immunoassay
45. A novel Western blot test containing both viral and recombinant proteins for anticytomegalovirus immunoglobulin M detection
46. Evaluation of two novel immunoassays using recombinant antigens to detect cytomegalovirus-specific immunoglobulin M in sera from pregnant women
47. Development and evaluation of a capture ELISA for IgM antibody to the human cytomegalovirus major DNA binding protein
48. International symposium on prevention of congenital rubella infection. Reviews of Infectious Diseases
49. Differentiation of primary cytomegalovirus infection from reactivation using the urea denaturation test for measuring antibody avidity
50. Value of cytomegalovirus (CMV) IgG avidity index for the diagnosis of primary CMV infection in pregnant women
51. Avidity of IgG antibodies distinguishes primary from non-primary cytomegalovirus infection in pregnant women
52. Differentiation between acute primary and recurrent human cytomegalovirus infection in pregnancy, using a microneutralization assay
53. The development of immunofluorescent antibodies as compared with complement-fixing and virus neutralizing antibodies in human cytomegalovirus infections
54. Microneutralization of cytomegalovirus
55. Quantification of human cytomegalovirus viremia by using monoclonal antibodies to different viral proteins
56. Rapid immunodiagnosis of active cytomegalovirus infection by monoclonal antibody staining of blood leukocytes
57. Comparison of different immunostaining techniques and monoclonal antibodies to the lower matrix phosphoprotein (pp65) for optimal quantitation of human cytomegalovirus antigenemia
58. Standardization of the human cytomegalovirus antigenemia assay by means of in vitro generated pp65-positive polymorphonuclear leukocytes
59. Quantitation of human cytomegalovirus DNA using the polymerase chain reaction
60. Comparative quantitation of human cytomegalovirus DNA in blood leukocytes and plasma of transplant and AIDS patients
61. Effect of foscarnet induction treatment on quantitation of human cytomegalovirus (HCMV) DNA in peripheral blood polymorphonuclear leukocytes and aqueous humor of AIDS patients with HCMV retinitis
62. Cytomegalovirus as a possible cause of disease resembling infectious mononucleosis
63. Spontaneous cytomegalovirus mononucleosis
64. Interaction of cytomegalovirus with leukocytes from patients with mononucleosis due to cytomegalovirus
65. Mechanisms of immunosuppression in cytomegaloviral monunucleosis
66. Mechanisms of immunosuppression in cytomegalovirus mononucleosis. II. Virus-monocyte interactions
67. Latent cytomegalovirus infection in blood donors
68. Persistence of cytomegalovirus in mononuclear cells in peripheral blood from blood donors
69. Monocytes are a major site of persistence of human cytomegalovirus in peripheral blood mononuclear cells
70. Polymerase chain reaction for detection of human cytomegalovirus infection in a blood donor population
71. Failure to detect human cytomegalovirus DNA in peripheral blood leukocytes of healthy blood donors by the polymerase chain reaction
72. Detection of cytomegalovirus in peripheral blood of patients infected with human immunodeficiency virus
73. Rapid detection of cytomegalovirus DNA and RNA in blood of renal transplant patients by in vitro enzymatic amplification
74. Detection of cytomegalovirus in blood donors by the polymerase chain reaction
75. Primer-mediated enzymatic amplification of cytomegalovirus (CMV) DNA. Application to the early diagnosis of CMV infections in marrow transplant recipients
76. Human cytomegalovirus in blood of immunocompetent persons during primary infection: Prognostic implications for pregnancy
77. Asymptomatic primary cytomegalovirus infection: Virologic and immunologic features
78. Prenatal diagnosis of congenital human cytomegalovirus infection
79. Requirements for diagnosis of prenatal cytomegalovirus infection by amniotic fluid culture
80. Polymerase chain reaction for prenatal diagnosis of congenital human cytomegalovirus infection
81. Improved prenatal diagnosis of congenital human cytomegalovirus infection by a modified nested polymerase chain reaction protocol
82. Intrauterine diagnosis of cytomegalovirus infection: Viral recovery from amniocentesis fluid
83. Prenatal diagnosis of congenital cytomegalovirus infection: Two decades later
84. Cytomegalovirus fetal infection: Prenatal diagnosis
85. Prenatal diagnosis of fetal cytomegalovirus infection
86. Prenatal diagnosis of congenital cytomegalovirus infection by virus isolation after amniocentesis
87. Prenatal diagnosis of fetal cytomegalovirus infection
88. Prenatal diagnosis of 52 pregnancies at risk for congenital cytomegalovirus infection
89. Prenatal diagnosis of fetal primary cytomegalovirus infection
90. Prenatal diagnostic and prognostic value of human cytomegalovirus load and IgM antibody response in blood of congenitally infected fetuses
91. Prenatal diagnosis of congenital cytomegalovirus infection: False-negative amniocentesis at 20 weeks gestation
92. Prenatal diagnosis of congenital cytomegalovirus infection
93. Quantification of human cytomegalovirus DNA in amniotic fluid of mothers of congenitally infected fetuses
94. Prenatal treatment of congenital human cytomegalovirus infection by fetal intravascular administration of ganciclovir
95. Intraperitoneal administration of cytomegalovirus hyperimmunoglobulin to the cytomegalovirus-infected fetus
96. Cytomegalovirus screening in pregnancy
97. Preconception cytomegalovirus antibody screening
98. Cytomegalovirus infection in pregnancy: Preliminary findings from a prospective study
99. Summary of a workshop on surveillance for congenital cytomegalovirus disease
100. Prevention of congenital cytomegalovirus disease (reply)
101. Cytomegalovirus
102. Prevention of child-to-mother transmission of cytomegalovirus by changing behaviors: A randomized controlled trial
103. Commentary: Is there a role for prenatal diagnosis of congenital cytomegalovirus infection?